Fierce Pharma13h
AstraZeneca signs Alteogen deal worth up to $1.35B for subcutaneous cancer drugs despite Merck-Halozyme patent drama
AstraZeneca has signed two deals worth $1.35 billion with Alteogen to develop subcutaneous versions of the British pharma’s ...
California Lutheran University11h
Cal Lutheran School of Management Joins March Madness
Cal Lutheran students, faculty, and staff will have a chance to compete against each other for the title of Boss ...
California Lutheran University11h
Cal Lutheran School of Management Leads Travel Seminar to Barcelona
The School of Management lead a course that invited students to study in Spain. The School of Management recognized three ...